Skip to Main Content

Paper Details

UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab.
Pharmacogenomics J
1
2022
RA, Sarilumab, UGT1A1, UGT1A1 gene, UGT1A1 genetic variants, aminotransferase, bilirubin, human, interleukin (IL)-6R, liver injury, patients, rheumatoid arthritis, rs4148325, sarilumab
Author NameAffiliation
Jennifer D HamiltonRegeneron Pharmaceuticals, Inc.
Sara C HamonRegeneron Pharmaceuticals, Inc.
John PennRegeneron Pharmaceuticals, Inc.
John Penn
Alexander LopezRegeneron Pharmaceuticals, Inc.
Jeffrey G ReidRegeneron Pharmaceuticals, Inc.
Jeffrey G ReidRegeneron Pharmaceuticals, Inc.
John D OvertonRegeneron Pharmaceuticals, Inc.
John D OvertonRegeneron Pharmaceuticals, Inc.
Alan R ShuldinerRegeneron Pharmaceuticals, Inc.
Alan R ShuldinerRegeneron Pharmaceuticals, Inc.
Gon??alo R AbecasisRegeneron Pharmaceuticals, Inc.
Gon??alo R AbecasisRegeneron Pharmaceuticals, Inc.
Aris BarasRegeneron Pharmaceuticals, Inc.
  • 1 - 14

Datasets

Release 1.2